Remove Documentation Remove Dosage Remove Information
article thumbnail

Renal Drug Dosing References

RX Note

Introduction Individualization of a drug dosage regimen for a patient with impaired kidney function is based on the pharmacodynamic/pharmacokinetic characteristics of the drug, the patient's degree of residual renal function, and the patient's overall clinical condition.

Dosage 40
article thumbnail

Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website?

Pharmacy Joe

Subscribe on iTunes , Android , or Stitcher If you navigate to the page on the website for the Institute for Safe Medication Practices that once hosted the document titled “Oral Dosage Forms That Should Not Be Crushed” you will instead find a notice that the list has been removed from the ISMP website.

Dosage 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How authentication of drugs has become a fundamental pillar of patient safety

Express Pharma

Counterfeit drugs, intentionally mislabeled or misrepresented, often contain substandard or harmful ingredients, incorrect dosages, or no active ingredients at all. By accurately documenting the movement of drugs, manufacturers can identify any quality issues that may arise during production, storage, or transportation.

article thumbnail

Navigating the regulatory landscape for nutraceutical startups in India

Express Pharma

As a result, nutraceutical startups need to stay informed about the latest regulatory changes and requirements in the states where they do business. This includes accurately labelling their products with all required information, such as ingredients, dosage recommendations, and potential allergens.

article thumbnail

How to ensure quality and compliance in clinical supply chain management

GMPSOP

To maintain the integrity and safety of these investigational products, you must adhere to Good Manufacturing Practice (GMP), FDA Clinical Trail Guidance Documents , and relevant ISO or EN standards. Additional documents included each month. Additional documents included each month. ensure traceability and compliance.

article thumbnail

Draft Guidance on Biosimilars and Interchangeables Tries to Smooth Path for Post-Approval Changes

FDA Law Blog: Biosimilars

Part 601.12 , and then offers additional information and discussion about what FDA expects to see from applicants who are intent on ensuring quality. The draft guidance reminds applicants that FDA must approve or note any missing information in a CBE-30 supplement within 30 days before an applicant distributes the product.

article thumbnail

Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website?

Pharmacy Joe

Subscribe on iTunes , Android , or Stitcher If you navigate to the page on the website for the Institute for Safe Medication Practices that once hosted the document titled “Oral Dosage Forms That Should Not Be Crushed” you will instead find a notice that the list has been removed from the ISMP website.

Dosage 52